pillbase.ru

Bowel Pathogen Nosode 4005

Wirkstoff: ANCYLOSTOMA DUODENALE, AMOEBA PROTEUS, PHERETIMA ASPERGILLUM, ASCARIS LUMBRICOIDES, BLASTOCYSTIS HOMINIS, CLOSTRIDIUM BOTULINUM, HELICOBACTER PYLORI, CITROBACTER FREUNDII, CLOSTRIDIUM PERFRINGENS, CRYPTOSPORIDIUM HOMINIS, DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN, ENTEROCOCCUS FAECIUM, ESCHERICHIA COLI, GIARDIA LAMBLIA, NECATOR AMERICANUS, ECHINOCOCCUS GRANULOSUS

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · ANCYLOSTOMA DUODENALE 30 [hp_X]/59mL, AMOEBA PROTEUS 30 [hp_X]/59mL, PHERETIMA ASPERGILLUM 30 [hp_X]/59mL, ASCARIS LUMBRICOIDES 30 [hp_X]/59mL, BLASTOCYSTIS HOMINIS 30 [hp_X]/59mL, CLOSTRIDIUM BOTULINUM 30 [hp_X]/59mL, HELICOBACTER PYLORI 30 [hp_X]/59mL, CITROBACTER FREUNDII 30 [hp_X]/59mL, CLOSTRIDIUM PERFRINGENS 30 [hp_X]/59mL, CRYPTOSPORIDIUM HOMINIS 30 [hp_X]/59mL, DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN 30 [hp_X]/59mL, ENTEROCOCCUS FAECIUM 30 [hp_X]/59mL, ESCHERICHIA COLI 30 [hp_X]/59mL, GIARDIA LAMBLIA 30 [hp_X]/59mL, NECATOR AMERICANUS 30 [hp_X]/59mL, ECHINOCOCCUS GRANULOSUS 30 [hp_X]/59mL

Vereinigte StaatenAktiv

Zulassungsinhaber: Professional Complementary Health Formulas

Geprüft 2026-10-09 · openFDA NDC

Zusammensetzung
  • ANCYLOSTOMA DUODENALE · 30 [hp_X]/59mL
  • AMOEBA PROTEUS · 30 [hp_X]/59mL
  • PHERETIMA ASPERGILLUM · 30 [hp_X]/59mL
  • ASCARIS LUMBRICOIDES · 30 [hp_X]/59mL
  • BLASTOCYSTIS HOMINIS · 30 [hp_X]/59mL
  • CLOSTRIDIUM BOTULINUM · 30 [hp_X]/59mL
  • HELICOBACTER PYLORI · 30 [hp_X]/59mL
  • CITROBACTER FREUNDII · 30 [hp_X]/59mL
  • CLOSTRIDIUM PERFRINGENS · 30 [hp_X]/59mL
  • CRYPTOSPORIDIUM HOMINIS · 30 [hp_X]/59mL
  • DIPHTHERIAL RESPIRATORY PSEUDOMEMBRANE HUMAN · 30 [hp_X]/59mL
  • ENTEROCOCCUS FAECIUM · 30 [hp_X]/59mL
  • ESCHERICHIA COLI · 30 [hp_X]/59mL
  • GIARDIA LAMBLIA · 30 [hp_X]/59mL
  • NECATOR AMERICANUS · 30 [hp_X]/59mL
  • ECHINOCOCCUS GRANULOSUS · 30 [hp_X]/59mL
Zulassung
Zulassungsnummer
63083-4005
Zulassungsstatus
Aktiv
Abgabe
Rezeptfrei
Art der Anwendung
ORAL
Quellen